2025-521981-90-00招募中1 期
A Study Testing the Investigational Drug XmAb541 in people with Advanced Cancer
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Xencor Inc.
- 入组人数
- 70
- 试验地点
- 14
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Dr. Mira Kistler
Scientific
Xencor Inc.
研究点 (14)
Loading locations...
相似试验
招募中
1 期
A study to test a new immunotherapy, ABX-001, alone and in combination with the marketed drug, pembrolizumab, for the treatment of tumors previously treated with other therapies.2024-512403-39-01Abalos Therapeutics GmbH27
招募中
1 期
A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune DiseasesSjögren's DiseaseSystemic SclerosisNCT07284797Xencor, Inc.60
招募中
1 期
The effect of SYX-5219 on an immune response in the skin.2025-522217-27-00Sitryx Therapeutics Limited20
招募中
1 期
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsEndometrial CancerTesticular Germ Cell TumorOvarian Germ Cell TumorOvarian CancerGerm Cell TumorNCT06276491Xencor, Inc.282
撤回
1 期
A study to test a new immunotherapy, ABX-001, alone and in combination with the marketed drug, pembrolizumab, for the treatment of tumors previously treated with other therapies.2024-512403-39-00Abalos Therapeutics GmbH27